I SURE LIKE THIS PAST OF THE PR.DAMN."We are excited that we were able to not only sell our Nutra Yu subsidiary for a profit, but also negotiate a royalty agreement at the same time. This will not only give Full Alliance cash needed for our 2020 and 2021 strategic plans, but will also allow us to tap into the growth of Nutra Yu at the same time. The profits seen with the Nutra Yu product line over the past quarter have been impressive," said new CEO Rudy Kiste. "On a separate note, we are excited with the new changes and additions to our executive and director boards. I am looking forward to taking on my new position with the company, so that Dr Volpp can focus on the medical consulting and strategic planning that is needed to better support our EBO2 subsidiary. And I am also excited to add someone with Ryan's business acumen to our Board of Directors."
Sincerely,
Rudy Kiste
CEO & President
News 
Market Data 
Discover 
